| abstract |
The present invention provides small compounds that target TACC3. Further provided are medicaments, in particular anticancer agents, comprising small compounds that target TACC3. The compound represented by the general formula (I), a pharmaceutically acceptable salt, solvate or ester derivative thereof binds to TACC3 and suppresses cell proliferation. Therefore, these compounds can be used as medicines, particularly as anticancer agents. |